CellSeed Inc. (7776) Other
Market cap
¥11.5B
P/E ratio
-9.8x
Cellseed develops cell sheet regenerative medicine technology to treat diseases that conventional therapies cannot cure, serving researchers and patients globally.
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | -3.1 | -37.8 | -20.1 | 14.4 | -14.8 | -10.6 | -13.2 | -12.6 | -13.1 | -7.4 | -12.4 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 68 | 20 | 18 | 20 | 28 | 33 | 37 | 39 | 40 | 40 | 44 | 30 | 35 | 38 | 36 |